RT Journal Article
SR Electronic
T1 Bisolvon
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 89
OP 90
DO 10.1136/dtb.7.23.89
VO 7
IS 23
YR 1969
UL http://dtb.bmj.com/content/7/23/89.abstract
AB Bromhexine hydrochloride (Bisolvon - Boehringer Ingelheim) has been used on the continent for some years, and is now being promoted in Britain as a ‘New Fundamental Approach to the Problem of Sputum’. The makers suggest that it should be used in acute and chronic bronchitis and other conditions where tenacious sputum is a problem. They claim first that it disrupts the felt-work of acid mucopolysaccharide film in mucoid broncial secretions, reducing their viscosity, and second that this eases expectoration.